That additional mechanism appears to increase energy expenditure beyond what tirzepatide produces
[46] Some authors have proposed that semaglutide can potentially suppress cholecystokinin secretion, reduce gallbladder emptying, and prolong gallbladder refilling, or a combination of these factors contributing to gallbladder disease
But a stronger GLP-1 weight loss program pairs appetite support with a clear plan: what to eat, how much protein to get, how to stay hydrated, how to manage side effects, how to protect muscle, and how to keep momentum once the scale starts moving
Prior authorizations, insurance rejections, and coverage clarifications are more frequent for obesity indications
Outcome: CGM-guided dosing achieved ~90 % time-in-range vs ~60 % with point-of-care monitoring
Both medications can lower blood glucose levels, and when used together, this effect might become too strong